Will 20+ countries introduce injectable lenacapavir for HIV prevention by 2027?
1
Ṁ100Ṁ12027
50%
chance
1H
6H
1D
1W
1M
ALL
Lenacapavir is a twice-yearly injectable HIV pre-exposure prophylaxis (PrEP) option recommended by WHO in 2025.
Resolves YES if at least 20 countries have introduced lenacapavir for HIV prevention by 31 December 2027, based primarily on WHO reporting.
“Introduced” means implementation for HIV prevention has begun in the country, rather than simply regulatory approval, a planned introduction or participation in a clinical trial.
This question is managed and resolved by Manifold.
Get
1,000 to start trading!
People are also trading
Related questions
Will a vaccine for HIV be approved by the FDA and be available for public use by 2027?
8% chance
Will a vaccine for HIV be a available in the US or Europe by 2030?
37% chance
Will prompt injection be effectively solved by end of 2026?
10% chance
Will 30 or more African countries be offering malaria vaccines by the end of 2027?
50% chance
Will there be an Opioid Vaccine available by the end of 2026?
5% chance
Will a vaccine for HIV be approved by the FDA by 2030?
62% chance
[Metaculus] Before 2032, will a vaccine against HIV-1 be approved by the USA, UK, EU, or Canada?
76% chance
Will there be an FDA approved cure for AIDS/HIV by EOY 2032?
55% chance
If a human challenge trial for a hepatitis C vaccine is NOT completed by the end of 2024, will a hep C vaccine be approved by the end of 2027?
46% chance
HIV Vaccine fully approved by FDA and commercially available before 2035?
37% chance